Mobious Genomics

Mobius Genomics is a South Korean biotechnology company specializing in advanced genomic sequencing and bioinformatics solutions. The company focuses on the detection of complex structural variations and phased variants using long-read sequencing technologies, which offer superior resolution compared to traditional short-read methods. Their proprietary analysis platform, M-SV, is designed to improve the diagnostic yield for rare genetic diseases and provide deeper insights into cancer genomics. Mobius Genomics serves clinical researchers and healthcare providers by offering both sequencing services and specialized software for genomic data interpretation. Through its innovative approach, the company aims to accelerate the implementation of precision medicine and enhance the accuracy of genetic testing.